128 related articles for article (PubMed ID: 32579977)
1. The nicotinic α7 receptor agonist GTS-21 but not the nicotinic α4β2 receptor agonist ABT-418 attenuate the disrupting effects of anesthetic ketamine on recognition memory in rats.
Pitsikas N
Behav Brain Res; 2020 Sep; 393():112778. PubMed ID: 32579977
[TBL] [Abstract][Full Text] [Related]
2. Flumazenil but not bicuculline counteract the impairing effects of anesthetic ketamine on recognition memory in rats. Evidence for a functional interaction between the GABA
Lafioniatis A; Bermperian VC; Pitsikas N
Neuropharmacology; 2019 Apr; 148():87-95. PubMed ID: 30597159
[TBL] [Abstract][Full Text] [Related]
3. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
Pitsikas N; Markou A
Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
[TBL] [Abstract][Full Text] [Related]
4. Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.
Callahan PM; Terry AV; Tehim A
Psychopharmacology (Berl); 2014 Sep; 231(18):3695-706. PubMed ID: 24595504
[TBL] [Abstract][Full Text] [Related]
5. The novel dehydroepiandrosterone derivative BNN27 counteracts the impairing effects of anesthetic ketamine on rats' non-spatial and spatial recognition memory.
Pitsikas N; Zoupa E; Gravanis A
Behav Brain Res; 2022 Jul; 430():113937. PubMed ID: 35644273
[TBL] [Abstract][Full Text] [Related]
6. Crocins, the Bioactive Components of
Pitsikas N; Tarantilis PA
Molecules; 2021 Jan; 26(3):. PubMed ID: 33498440
[TBL] [Abstract][Full Text] [Related]
7. Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory.
Pitsikas N; Boultadakis A; Sakellaridis N
Neuroscience; 2008 Jun; 154(2):454-60. PubMed ID: 18472348
[TBL] [Abstract][Full Text] [Related]
8. Anesthetic ketamine impairs rats' recall of previous information: the nitric oxide synthase inhibitor N-nitro-L-arginine methylester antagonizes this ketamine-induced recognition memory deficit.
Boultadakis A; Pitsikas N
Anesthesiology; 2011 Jun; 114(6):1345-53. PubMed ID: 21478733
[TBL] [Abstract][Full Text] [Related]
9. The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
Boess FG; De Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Riedl B; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; Koenig G
J Pharmacol Exp Ther; 2007 May; 321(2):716-25. PubMed ID: 17308038
[TBL] [Abstract][Full Text] [Related]
10. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
[TBL] [Abstract][Full Text] [Related]
11. α₄β₂ Nicotinic receptor stimulation of the GABAergic system within the orbitofrontal cortex ameliorates the severe crossmodal object recognition impairment in ketamine-treated rats: implications for cognitive dysfunction in schizophrenia.
Cloke JM; Winters BD
Neuropharmacology; 2015 Mar; 90():42-52. PubMed ID: 25460188
[TBL] [Abstract][Full Text] [Related]
12. Pre-training administration of anesthetic ketamine differentially affects rats' spatial and non-spatial recognition memory.
Pitsikas N; Boultadakis A
Neuropharmacology; 2009 Jul; 57(1):1-7. PubMed ID: 19376140
[TBL] [Abstract][Full Text] [Related]
13. Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats.
Nikiforuk A; Litwa E; Krawczyk M; Popik P; Arias H
Pharmacol Rep; 2020 Jun; 72(3):589-599. PubMed ID: 32207091
[TBL] [Abstract][Full Text] [Related]
14. The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.
Cannon CE; Puri V; Vivian JA; Egbertson MS; Eddins D; Uslaner JM
Neuropharmacology; 2013 Jan; 64():191-6. PubMed ID: 22659472
[TBL] [Abstract][Full Text] [Related]
15. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
Potasiewicz A; Hołuj M; Kos T; Popik P; Arias HR; Nikiforuk A
Neuropharmacology; 2017 Feb; 113(Pt A):188-197. PubMed ID: 27717880
[TBL] [Abstract][Full Text] [Related]
16. EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
Prickaerts J; van Goethem NP; Chesworth R; Shapiro G; Boess FG; Methfessel C; Reneerkens OA; Flood DG; Hilt D; Gawryl M; Bertrand S; Bertrand D; König G
Neuropharmacology; 2012 Feb; 62(2):1099-110. PubMed ID: 22085888
[TBL] [Abstract][Full Text] [Related]
17. Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors.
Moaddel R; Abdrakhmanova G; Kozak J; Jozwiak K; Toll L; Jimenez L; Rosenberg A; Tran T; Xiao Y; Zarate CA; Wainer IW
Eur J Pharmacol; 2013 Jan; 698(1-3):228-34. PubMed ID: 23183107
[TBL] [Abstract][Full Text] [Related]
18. Crocins, the active constituents of Crocus Sativus L., counteracted ketamine-induced behavioural deficits in rats.
Georgiadou G; Grivas V; Tarantilis PA; Pitsikas N
Psychopharmacology (Berl); 2014 Feb; 231(4):717-26. PubMed ID: 24096536
[TBL] [Abstract][Full Text] [Related]
19. A Novel Multisensory Integration Task Reveals Robust Deficits in Rodent Models of Schizophrenia: Converging Evidence for Remediation via Nicotinic Receptor Stimulation of Inhibitory Transmission in the Prefrontal Cortex.
Cloke JM; Nguyen R; Chung BY; Wasserman DI; De Lisio S; Kim JC; Bailey CD; Winters BD
J Neurosci; 2016 Dec; 36(50):12570-12585. PubMed ID: 27974613
[TBL] [Abstract][Full Text] [Related]
20. Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits.
Vieira-Brock PL; McFadden LM; Nielsen SM; Smith MD; Hanson GR; Fleckenstein AE
Int J Neuropsychopharmacol; 2015 Jul; 18(12):. PubMed ID: 26164716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
